Author:
Gunaratne Naiomi,Deplewski Dianne
Abstract
The prevalence of pediatric obesity has been increasing during the last 30 years, and the subsequent metabolic consequences of obesity, which were mainly seen in adults, are now presenting in childhood. Type 2 diabetes, prediabetes, metabolic syndrome, and nonalcoholic fatty liver disease are serious metabolic ramifications of pediatric obesity; pediatricians need to be familiar in screening and treatment of these metabolic issues. This review will discuss the inflammation and insulin resistance involved in obesity that can lead to these conditions. We will explore the pathophysiology of type 2 diabetes and prediabetes, metabolic syndrome, and nonalcoholic fatty liver disease and review screening and treatment modalities. Finally, we will highlight other important endocrine related comorbidities in pediatric obesity, including polycystic ovary syndrome, precocious puberty, and early accelerated growth.
[
Pediatr Ann
. 2023;52(2):e62–e67.]
Subject
Pediatrics, Perinatology and Child Health
Reference28 articles.
1. Prevalence of Obesity and Severe Obesity in US Children, 1999–2016
2. Stierman B, Afful J, Carroll MD. National Health and Nutrition Examination Survey 2017–March 2020 Prepandemic Data Files—Development of Files and Prevalence Estimates for Selected Health Outcomes. National Center for Health Statistics; 2021. Accessed January 31, 2023. https://stacks.cdc.gov/view/cdc/106273
3. The adipokines and inflammatory status in the era of pediatric obesity
4. Pediatric Obesity and the Immune System
5. Obesity, metabolic syndrome, and disorders of energy balance
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献